文献速递肾癌与肾肿瘤

局限性肾肿块患者共享决策预测模型:系统综述与医患优先级调查

Prediction Models for Shared Decision-making by Patients with Localised Renal Masses: A Systematic Review and a Survey of Patient and Clinician Priorities.
PubMed 文献 · Eur Urol Oncol · 2026-02-25

该系统综述筛选6833条记录,纳入284项研究,覆盖九大类预测模型;195项开发原创模型的研究中,79项(40.5%)提供可用于患者决策的列线图,105项(53.8%)未验证新模型。

要点

  • 现有局限性肾肿块预测模型众多但无广泛使用者,且多数缺乏验证。
  • 仅40.5%的原创模型提供可用于患者决策的列线图,53.8%未验证。
  • 医患调查确定六个优先领域,无单一模型充分覆盖全部优先领域。

核心结论

  • 现有局限性肾肿块预测模型异质性强,无单一模型充分覆盖医患共同优先领域,临床实用性不明确。
  • 未来模型应包含临床相关输出、明确开发队列性质和模型性能,并提供用户友好版本供患者获取信息。

研究设计与样本

  • 系统综述(PROSPERO 1048873)筛选6833条记录,纳入284项研究,覆盖九大类预测模型。
  • 在线调查由31名临床医生和35名患者/照护者完成,确定治疗新诊断局限性肾肿块的六个优先领域。

主要发现

  • 284项纳入研究覆盖九大类:良恶性、具体病理、分级、不良病理、生存、基因组学、肾功能、并发症、技术因素。
  • 101项研究使用现有列线图(主要为肾脏测量评分)。
  • 195项开发原创模型的研究中,79项(40.5%)提供可用于患者决策的列线图,105项(53.8%)未验证新模型。

关键数值与推荐

  • 195项原创模型研究中79项(40.5%)提供可用于患者决策的列线图。
  • 195项原创模型研究中105项(53.8%)未对新模型进行验证。

临床怎么用

  • 临床医生选择局限性肾肿块预测模型辅助共享决策时,需注意多数模型缺乏验证且无单一模型覆盖全部医患优先领域。
  • 未来模型开发应纳入临床相关输出、明确开发队列和性能,并提供用户友好版本供患者使用。

局限性

  • 在线调查样本量小(31名临床医生和35名患者/照护者),需进一步研究充分评估医患优先级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Counselling a patient with a localised renal mass (LRM) can be complex. While many models can predict various outcomes (nature of the mass, survival, technical points of the intervention), none is widely used. We conducted a systematic review of models that could potentially be used to assist patients' decision-making for LRMs (PROSPERO 1048873). Among 6833 records screened, 284 met the inclusion criteria covering nine broad categories (benign vs malignant, specific pathology, grade, adverse pathology, survival, genomics, renal function, complications, technical factors), of which 101 used existing nomograms (predominantly nephrometry scores). Of the 195 studies that developed an original model, 79 (40.5%) provided a nomogram that could be used for patient decision-making, while 105 (53.8%) provided no validation for the new model. We conducted an online survey that was completed by 31 clinicians and 35 patients/carers and identified six priority areas when considering treatment for a newly diagnosed LRM. Twenty models covered aspects of these priority areas, but no single model adequately covered them all. Further research is required for proper assessment of clinician and patient/carer priorities, but the results from our review and the survey that included multiple stakeholders provide clarity on clinical utility across the heterogeneous field of models available. The design of future models should include clinically relevant outputs, should clearly state the nature of the development cohort and model performance, and should ideally provide a user-friendly version of the model via which patients can obtain relevant information.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Blackmur JP, Rossi SH, Kuusk T, et al. Prediction Models for Shared Decision-making by Patients with Localised Renal Masses: A Systematic Review and a Survey of Patient and Clinician Priorities. Eur Urol Oncol. 2026. PMID: 41748360. doi:10.1016/j.euo.2026.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。